Menu
Currency
GWAS Study

Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program.

Hu Y, Stilp AM, McHugh CP et al.

33887194 PubMed ID
GWAS Study Type
62487 Participants
80 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HY
Hu Y
SA
Stilp AM
MC
McHugh CP
RS
Rao S
JD
Jain D
ZX
Zheng X
LJ
Lane J
MD
Méric de Bellefon S
RL
Raffield LM
CM
Chen MH
YL
Yanek LR
WM
Wheeler M
YY
Yao Y
RC
Ren C
BJ
Broome J
MJ
Moon JY
DV
de Vries PS
HB
Hobbs BD
SQ
Sun Q
SP
Surendran P
BJ
Brody JA
BT
Blackwell TW
CH
Choquet H
RK
Ryan K
DR
Duggirala R
HN
Heard-Costa N
WZ
Wang Z
CN
Chami N
PM
Preuss MH
MN
Min N
EL
Ekunwe L
LL
Lange LA
CM
Cushman M
FN
Faraday N
CJ
Curran JE
AL
Almasy L
KK
Kundu K
SA
Smith AV
GS
Gabriel S
RJ
Rotter JI
FM
Fornage M
LD
Lloyd-Jones DM
VR
Vasan RS
SN
Smith NL
NK
North KE
BE
Boerwinkle E
BL
Becker LC
LJ
Lewis JP
AG
Abecasis GR
HL
Hou L
OJ
O'Connell JR
MA
Morrison AC
BT
Beaty TH
KR
Kaplan R
CA
Correa A
BJ
Blangero J
JE
Jorgenson E
PB
Psaty BM
KC
Kooperberg C
WR
Walton RT
KB
Kleinstiver BP
TH
Tang H
LR
Loos RJF
SN
Soranzo N
BA
Butterworth AS
ND
Nickerson D
RS
Rich SS
MB
Mitchell BD
JA
Johnson AD
AP
Auer PL
LY
Li Y
MR
Mathias RA
LG
Lettre G
PN
Pankratz N
LC
Laurie CC
LC
Laurie CA
BD
Bauer DE
CM
Conomos MP
RA
Reiner AP
Chapter II

Abstract

Summary of the research findings

Whole-genome sequencing (WGS), a powerful tool for detecting novel coding and non-coding disease-causing variants, has largely been applied to clinical diagnosis of inherited disorders. Here we leveraged WGS data in up to 62,653 ethnically diverse participants from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program and assessed statistical association of variants with seven red blood cell (RBC) quantitative traits. We discovered 14 single variant-RBC trait associations at 12 genomic loci, which have not been reported previously. Several of the RBC trait-variant associations (RPN1, ELL2, MIDN, HBB, HBA1, PIEZO1, and G6PD) were replicated in independent GWAS datasets imputed to the TOPMed reference panel. Most of these discovered variants are rare/low frequency, and several are observed disproportionately among non-European Ancestry (African, Hispanic/Latino, or East Asian) populations. We identified a 3 bp indel p.Lys2169del (g.88717175_88717177TCT[4]) (common only in the Ashkenazi Jewish population) of PIEZO1, a gene responsible for the Mendelian red cell disorder hereditary xerocytosis (MIM: 194380), associated with higher mean corpuscular hemoglobin concentration (MCHC). In stepwise conditional analysis and in gene-based rare variant aggregated association analysis, we identified several of the variants in HBB, HBA1, TMPRSS6, and G6PD that represent the carrier state for known coding, promoter, or splice site loss-of-function variants that cause inherited RBC disorders. Finally, we applied base and nuclease editing to demonstrate that the sentinel variant rs112097551 (nearest gene RPN1) acts through a cis-regulatory element that exerts long-range control of the gene RUVBL1 which is essential for hematopoiesis. Together, these results demonstrate the utility of WGS in ethnically diverse population-based samples and gene editing for expanding knowledge of the genetic architecture of quantitative hematologic traits and suggest a continuum between complex trait and Mendelian red cell disorders.

33,324 Amish, White ancestry individuals, 654 Asian ancestry individuals, 14,474 Black individuals, 14,035 Central American ancestry, Cuban ancestry, Dominican ancestry, Mexican ancestry, Puerto Rican ancestry, South American ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

62487
Total Participants
GWAS
Study Type
No
Replicated
European, Asian unspecified, African American or Afro-Caribbean, Hispanic or Latin American
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.